INmune Bio Partners With Quantum Computing Inc. to Explore New XPro Uses
The collaboration will apply quantum optimization, AI and analytics to identify and prioritize potential XPro disease indications, starting with rare diseases.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
The collaboration will apply quantum optimization, AI and analytics to identify and prioritize potential XPro disease indications, starting with rare diseases.
INmune Bio entered a collaboration with Quantum Computing to apply quantum computing, AI, and analytics to expand research on XPro1595. Work will use QCi’s Dirac-3S quantum optimization machine with clinical and public datasets to identify new indications and biomarkers. Partnership targets diseases with biology aligne
Quantum Computing entered a collaboration with INmune Bio to apply quantum optimization, AI, and analytics to Alzheimer’s drug research. Work will use QCi’s Dirac-3S quantum optimization machine to identify new indications and biomarkers for INmune Bio’s XPro (XPro1595). Project will analyze INmune Bio clinical-trial d